Ifp Advisors, Inc Talaris Therapeutics, Inc. Transaction History

Ifp Advisors, Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 08, 2022	BUY	$2.3 - $5.03 $11,500 - $25,150	5,000 Added 1075.27%	5,465 $89,000
Q2 2022 Sep 06, 2022	BUY	$4.51 - $9.85 $2,097 - $4,580	465 New	465 $8,000
Q2 2022 Aug 12, 2022	SELL	$4.51 - $9.85 $2,097 - $4,580	-465 Closed	0 $0
Q1 2022 Sep 06, 2022	BUY	$6.89 - $16.56 $3,203 - $7,700	465 New	465 $4,000

75.7K

Ticker TALS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,995,900
Market Cap $109M
Description
Talaris Therapeutics, Inc. operates as a late-clinical stage cell therapy company in the United States. The company engages in developing a method of allogeneic hematopoietic stem cell transplantation to transform the standard of care in solid organ transplantation and severe autoimmune diseases, as well as severe non-malignant blood, immune, an...

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ifp Advisors, Inc with notifications on news.